Back
Ocugen Vs. NeuroBo Pharmaceuticals Industry Stock Comparison
Sell
45
OCGN
Ocugen
Last Price:
0.98
Seasonality Move:
364.7%
Sell
22
NRBO
NeuroBo Pharmaceuticals
Last Price:
2.35
Seasonality Move:
6.18%
Sell
45
Ocugen (OCGN)
is a Sell
Is Ocugen a Buy, Sell or Hold?
- The current Ocugen [OCGN] share price is $0.91. The Score for OCGN is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- OCGN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
22
NeuroBo Pharmaceuticals (NRBO)
is a Sell
Is NeuroBo Pharmaceuticals a Buy, Sell or Hold?
- The current NeuroBo Pharmaceuticals [NRBO] share price is $2.35. The Score for NRBO is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
- NRBO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
OCGN Stock Price Chart
NRBO Stock Price Chart
What is NeuroBo Pharmaceuticals's stock price today?
-
The NeuroBo Pharmaceuticals share price today is $2.35
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NRBO is experiencing slight selling pressure.
OCGN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 44.9 | Sell |
| Chaikin Money Flow: | -1241898 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.9 - 1) | Sell |
| Bollinger Bands (100): | (0.91 - 1.47) | Sell |
NRBO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.13 | Sell |
| Relative Strength Index (14 RSI): | 40.34 | Sell |
| Chaikin Money Flow: | -5462 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.38 - 2.76) | Sell |
| Bollinger Bands (100): | (2.65 - 4.07) | Sell |
OCGN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.91 | Sell |
| 20-day SMA: | 0.96 | Sell |
| 50-day SMA: | 0.97 | Sell |
| 200-day SMA: | 1.3 | Sell |
| 8-day EMA: | 0.92 | Sell |
| 20-day EMA: | 0.94 | Sell |
| 50-day EMA: | 1.01 | Sell |
| 200-day EMA: | 1.14 | Sell |
NRBO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.36 | Sell |
| 20-day SMA: | 2.51 | Sell |
| 50-day SMA: | 2.76 | Sell |
| 200-day SMA: | 3.83 | Sell |
| 8-day EMA: | 2.4 | Sell |
| 20-day EMA: | 2.51 | Sell |
| 50-day EMA: | 2.79 | Sell |
| 200-day EMA: | 4.65 | Sell |
Ocugen Earnings Growth & OCGN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and a decrease next year of $0.07 per share.
NeuroBo Pharmaceuticals Earnings Growth & NRBO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Ocugen Technical Analysis
| Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NeuroBo Pharmaceuticals Technical Analysis
| Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||